Literature DB >> 6253395

Antivirus antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection.

J E Manischewitz, G V Quinnan.   

Abstract

BALB/c mice infected with murine cytomegalovirus were studied to determine whether antibody-dependent cell-mediated cytotoxicity contributes to the immune control of this infection. Antibody-dependent killer cells from uninfected mice were used as effector cells to assay for antibody in sera of infected mice. Secondary immune sera were found to contain both cytomegalovirus-specific and autoreactive antibodies. After primary infection only cytomegalovirus-specific antibodies were found. These were detected by antibody-dependent cell-mediated cytotoxicity within 8 to 10 days after onset of infection, but usually not until day 21, by a neutralizing antibody assay. Antibody titers were about 10-fold higher by antibody-dependent cell-mediated cytotoxicity than by neutralization. The results indicate that cellular immunity to cytomegalovirus infection includes an antibody-dependent cell-mediated cytotoxicity response which is likely to be highly efficient and may contribute significantly to control of both acute and later stages of infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253395      PMCID: PMC551237          DOI: 10.1128/iai.29.3.1050-1054.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Lysis of herpesvirus-infected cells by immune spleen cells.

Authors:  I A Ramshaw
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

2.  Immunosuppression reactivates and disseminates latent murine cytomegalovirus.

Authors:  M C Jordan; J D Shanley; J G Stevens
Journal:  J Gen Virol       Date:  1977-11       Impact factor: 3.891

3.  Immune destruction of virus-infected cells early in the infectious cycle.

Authors:  S L Shore; T L Cromeans; T J Romano
Journal:  Nature       Date:  1976-08-19       Impact factor: 49.962

4.  Immune control of herpes simplex virus infections.

Authors:  F A Ennis; M Wells
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

5.  Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells.

Authors:  F A Ennis
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

6.  The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.

Authors:  F M Melewicz; S L Shore; E W Ades; D J Phillips
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

7.  Comparative characteristics of three cytomegaloviruses from rodents.

Authors:  K S Kim; V Sapienza; R I Carp
Journal:  Am J Vet Res       Date:  1975-10       Impact factor: 1.156

8.  Mouse cytomegalovirus. Necrosis of infected and morphologically normal submaxillary gland acinar cells during termination of chronic infection.

Authors:  D Henson; A J Strano
Journal:  Am J Pathol       Date:  1972-07       Impact factor: 4.307

9.  The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.

Authors:  S L Shore; F M Melewicz; D S Gordon
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

10.  Human neutrophil--mediated destruction of antibody sensitized herpes simplex virus type I infected cells.

Authors:  Y Fujimiya; B T Rouse; L A Babiuk
Journal:  Can J Microbiol       Date:  1978-02       Impact factor: 2.419

View more
  10 in total

Review 1.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

2.  Susceptibility of W/WV mice to murine cytomegalovirus infection.

Authors:  T Ohashi; Y Nawa; Y Minamishima; M Owhashi
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.

Authors:  Julie H Ishida; Anita Patel; Aneesh K Mehta; Philippe Gatault; Jacqueline M McBride; Tracy Burgess; Michael A Derby; David R Snydman; Brinda Emu; Becket Feierbach; Ashley E Fouts; Mauricio Maia; Rong Deng; Carrie M Rosenberger; Lynn A Gennaro; Natalee S Striano; X Charlene Liao; Jorge A Tavel
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

4.  Cytomegalovirus-specific cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers.

Authors:  N Kirmani; R K Ginn; K K Mittal; J F Manischewitz; G V Quinnan
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

5.  Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication.

Authors:  G V Quinnan; J F Manischewitz
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

6.  An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host.

Authors:  F S Stals; F Bosman; C P van Boven; C A Bruggeman
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  The induction of murine cytotoxic T lymphocytes by bluetongue virus.

Authors:  M H Jeggo; R C Wardley
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

8.  Murine cytomegalovirus-induced immunosuppression.

Authors:  L Loh; J B Hudson
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

9.  Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice.

Authors:  J F Bukowski; B A Woda; R M Welsh
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

10.  Protective effect of biological response modifiers on murine cytomegalovirus infection.

Authors:  K Ebihara; Y Minamishima
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.